Search
for
Sort by
Research 421–450 of 1000+
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- An Update of Congenital Adrenal Hyperplasia
- The Role of Vitamins and Minerals in Hair Loss: A Review
- TGF-β family signaling in stem cells
- Obesity and the skin
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Regulatory T cells in skin
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Baiting Proteins with C<sub>60</sub>
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Cutaneous reactions to recombinant cytokine therapy
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Protection Against Chemotherapy-Induced Alopecia
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Physiologic functions of PP2A: Lessons from genetically modified mice
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Toxic Epidermal Necrolysis
- Repurposing of approved cardiovascular drugs
- Insulin Resistance and Skin Diseases
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Endocrine Influences on Hair Growth
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- Assessment of the obese patient
- Androgen receptors and their biology
- Dienogest
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Androgens in women